Profound Medical Corp. (NASDAQ: PROF) reported Q3 EPS of ($0.26), $0.08 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $2.17 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.